"Sanofi Aventis, the French pharmaceutical group, releases its full year results today and investors will be looking for any hint or indication of a potential interest in Oxford BioMedica. Rumours are rife that Sanofi is interested in acquiring the UK-listed biopharmaceutical firm, whose shares yesterday rose 5p, or 26.7%, to 23.75p"
http://www.guardian.co.uk/business/2008/feb/12/marketforces
Tuesday, February 12, 2008
OXB
